• Lead the Long-Term Care Account Management team – consisting of 1 National and 4 Regional Account Managers – driving demand with GPOs, National and Regional LTC Pharmacies, and National Nursing Home chains for GEMTESA® and APTIOM®. • Responsible for establishing team culture, structure and goals, account targeting, data consolidation, performance tracking, and coordination with LTC sales team for pull-through activities, • Increased revenue in LTC channel by 64% in first 6 months.

• Launched GEMTESA® for over-active bladder with Urovant and Sunovion Multi-Specialty teams.• Led GEMTESA Market Access co-promotion activities with Sunovion Pharmaceuticals, including collaboration with Account Managers, Multi-Specialty sales team, Trade, Marketing, Legal. Compliance, Medical, Regulatory, Finance.• Initiated and led cross-collaboration between Urovant and Sunovion Account Manager teams. Helped develop pull-through campaigns for formulary wins.• GEMTESA Patient… Show more • Launched GEMTESA® for over-active bladder with Urovant and Sunovion Multi-Specialty teams.• Led GEMTESA Market Access co-promotion activities with Sunovion Pharmaceuticals, including collaboration with Account Managers, Multi-Specialty sales team, Trade, Marketing, Legal. Compliance, Medical, Regulatory, Finance.• Initiated and led cross-collaboration between Urovant and Sunovion Account Manager teams. Helped develop pull-through campaigns for formulary wins.• GEMTESA Patient Access lead for patient inquires for cost and coverage challenges.• Created Market Access marketing assets for launch of Gemtesa®, working with agencies including legal and regulatory review. Show less

• Launched reimbursement team at Alkermes. Helped build structure for HUB interactions, field engagement, and education of provider staff on acquisition and reimbursement for Vivitrol (addiction recovery) and Aristada (schizophrenia), and facilitated sales partnership to increase HUB enrollments and order fulfillment.• Buy and bill expert. Created training programs for field reimbursement managers (FRM) and sale teams.• Partnered with HUB case managers to increase specialty pharmacy… Show more • Launched reimbursement team at Alkermes. Helped build structure for HUB interactions, field engagement, and education of provider staff on acquisition and reimbursement for Vivitrol (addiction recovery) and Aristada (schizophrenia), and facilitated sales partnership to increase HUB enrollments and order fulfillment.• Buy and bill expert. Created training programs for field reimbursement managers (FRM) and sale teams.• Partnered with HUB case managers to increase specialty pharmacy fulfillment from 39% to 62%, and improve fulfillment time from an average of 10 days to seven days.• Successfully collaborated with managed markets team to eliminate prior authorization (PA) restrictions for Vivitrol at Oregon Medicaid.• Subject matter expert on benefits verification, payer mapping, prior authorization, specialty pharmacy, and buy and bill.• Performance review: exceeds expectations. Show less

Leader of all managed care account activity. Responsibilities included maximizing medical and pharmacy formulary status, contract negotiations and profitability, and field sales pull-through. • Pinnacle Award (President’s Club) Winner with #1 ranking on account executive team (2017).• Washington Medicaid win (2018). Vimpat moved to preferred status, and removed a generic double step edit for 1.5M Washington Managed Medicaid patients. • Formulary win Regence BS/BCBS (2017). Cimzia… Show more Leader of all managed care account activity. Responsibilities included maximizing medical and pharmacy formulary status, contract negotiations and profitability, and field sales pull-through. • Pinnacle Award (President’s Club) Winner with #1 ranking on account executive team (2017).• Washington Medicaid win (2018). Vimpat moved to preferred status, and removed a generic double step edit for 1.5M Washington Managed Medicaid patients. • Formulary win Regence BS/BCBS (2017). Cimzia preferred access for pharmacy and medical benefit for 1.2M Regence patients. Developed and implemented Regence pull-through plan generating a 78% increase in sales. • Gained Cimzia medical access for 240,000 Moda Health patients by removing Cimzia from the self-administered drug list.• Established and maintained preferred and open access for Vimpat (anticonvulsant) with 86% of regional payers.• Successful 2016 new product launch of Briviact (anticonvulsant), utilizing medical science team in payer presentations, establishing open access for 60% of regional payers, and facilitating field sales pull-through. Show less

Provided leadership and training on all reimbursement activities for in-office administration of Cimzia. Responsibilities included working with Medicare - Noridian Medical Directors and Carrier Advisory Committee (CAC) members, and generating advocacy through state rheumatology and gastroenterology societies. • Instrumental in reversing decisions to eliminate Medicare Part B coverage for CIMZIA®: Noridian, a Medicare administrator contractor, intended to eliminate coverage. Solution:… Show more Provided leadership and training on all reimbursement activities for in-office administration of Cimzia. Responsibilities included working with Medicare - Noridian Medical Directors and Carrier Advisory Committee (CAC) members, and generating advocacy through state rheumatology and gastroenterology societies. • Instrumental in reversing decisions to eliminate Medicare Part B coverage for CIMZIA®: Noridian, a Medicare administrator contractor, intended to eliminate coverage. Solution: Developed relationship with the contractor’s medical directors and worked with state societies and influential physicians to advocate for Medicare patients. Decision reversed in 2011 and again in 2013.• Created CIMZIA® access and facilitated usage through matrix teamwork with eight sales representatives, two district managers, and a regional account executive. Excellent reputation for collaboration and communication with internal and external customers. Launched FRM team in 2009. Show less

Launched CIMZIA® for new indication for the treatment of rheumatoid arthritis (RA), Food and Drug Administration (FDA) approved in June 2009. Territory: WA, Portland, OR, and AK.• Spearheaded training and development in the NW district. Initiated and led medical science liaison (MSL) clinical conference calls and developed a reputation as a clinical expert in the district.• Ranked in top 20% of national sales force of 200 sales representatives.

Oncology Executive Sales Specialist, Zometa® and Femara®Marketed short infusion drug (buy & bill) for bone metastases, Zometa®, and an aromatase inhibitor for breast cancer, Femara®. Territory: Western WA and AK.• Increased Zometa® market share by 3% (88% - 91%), exceeding the national average by 16%, and consistently ranked in the top 15% of the national sales force in 2006 and 2007.• Won “Fast Start New Rx” contest for market share increases during the launch of… Show more Oncology Executive Sales Specialist, Zometa® and Femara®Marketed short infusion drug (buy & bill) for bone metastases, Zometa®, and an aromatase inhibitor for breast cancer, Femara®. Territory: Western WA and AK.• Increased Zometa® market share by 3% (88% - 91%), exceeding the national average by 16%, and consistently ranked in the top 15% of the national sales force in 2006 and 2007.• Won “Fast Start New Rx” contest for market share increases during the launch of Femara®.• Established relationships with oncologists and office staff from Bellingham to Centralia, WA, and AK. Show less

Senior Specialty Sales Representative, Lupron Depot® (Urology, Gynecology, Oncology)Sold Lupron Depot®, an injectable buy & bill drug, to urologists, oncologists, and gynecologists. Managed direct and indirect sales, reimbursements, Medicare, and managed care issues. Territory: Southwest WA.• Directly managed every aspect of account reimbursement (contracting, billing questions, coding information, insurance verification, and coverage for all commercial and government–managed care… Show more Senior Specialty Sales Representative, Lupron Depot® (Urology, Gynecology, Oncology)Sold Lupron Depot®, an injectable buy & bill drug, to urologists, oncologists, and gynecologists. Managed direct and indirect sales, reimbursements, Medicare, and managed care issues. Territory: Southwest WA.• Directly managed every aspect of account reimbursement (contracting, billing questions, coding information, insurance verification, and coverage for all commercial and government–managed care plans) utilized in the assigned territory. Promoted to Senior Sales Representative status within four years of hire.• Increased gynecology (GYN) sales volume by 65%, reflecting increases over 12 consecutive quarters. Maintained a 90% market share for Lupron® in urology physician practices for six consecutive years.• Served as district trainer, district computer trainer, certified field expert, and advisory board member. Show less